#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gaucher's disease type III Hereditary motor and sensory neuropathy Inclusion body myositis Cholangiocarcinoma Focal segmental glomerulosclerosis Glycogen storage disease type I Spinal muscular atrophy Biotinidase deficiency Small cell lung cancer limited stage Pulmonary sarcoidosis Dementia Breast cancer Bladder cancer Thrombocytosis Squamous cell carcinoma of the vulva More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome Tuberous sclerosis complex – Basic Information Waldenstrom’s macroglobulinaemia refractory – Life with Disease Myelodysplastic syndrome with excess blasts – Basic Information Systemic mastocytosis – Trials in Disease Lysosomal storage disorder – Life with Disease Bronchopulmonary dysplasia – Trials in Disease Synovial sarcoma metastatic – Diagnostics Primary hyperoxaluria – Life with Disease Breast angiosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Demeclocycline Hydrochloride Tadekinig Alfa Macrogol 4000 Fondaparinux Sodium Testosterone Undecanoate Recombinant Interferon Beta-1B Tramadol Hydrochloride Posaconazole Lysine Aspirin Acp-017 SRSD107 GSK4524101A Dexamethasone Acetate L-Lysine Acetate Betaxolol Natalizumab Estradiol Magnesium Stearate Candesartan Cilexetil Mycophenolic Acid More therapies…

    Learn about Your Condition

    Herpes zoster Cerebrovascular accident Netherton's syndrome Chondrosarcoma metastatic Lyme disease Kaposi's sarcoma Hairy cell leukaemia recurrent Impaired gastric emptying Schizoaffective disorder Transferrin decreased Hyperoxaluria Hyperparathyroidism primary Burning mouth syndrome Cataract Small intestine adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Factor VIII deficiency

  • Study on the Use of Simoctocog Alfa for Women and Girls with Hemophilia A Undergoing Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Simoctocog Alfa
    Finland France Germany Italy Romania Spain

  • Efficacy of efanesoctocog alfa in reducing synovitis in patients with congenital hemophilia A – a multicenter, randomized, open‑label phase 3 trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Synovitis
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Austria Germany

  • Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor IX deficiency
    • Factor VIII deficiency
    Investigated Drugs:
    • Efmoroctocog Alfa
    • Eftrenonacog Alfa
    Bulgaria Croatia Czechia France Hungary Ireland +4

  • A study looking at the safety of switching from emicizumab to denecimig in adults and adolescents with haemophilia A with or without inhibitors

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia A with anti factor VIII
    • Factor VIII deficiency
    Austria Belgium France Germany Italy Spain

  • Study on Emicizumab for Patients with Mild or Moderate Hemophilia A Without FVIII Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Emicizumab
    Belgium France Germany

  • Study on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Italy Norway Spain Sweden
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!